These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3067954
1. A double-blind cross-over study of nifedipine retard in patients with Raynaud's phenomenon. Finch MB, Copeland S, Passmore AP, Johnston GD. Clin Rheumatol; 1988 Sep; 7(3):359-65. PubMed ID: 3067954 [Abstract] [Full Text] [Related]
2. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study. Finch MB, Dawson J, Johnston GD. Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096 [Abstract] [Full Text] [Related]
3. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, Kirby JD. BMJ; 1989 Mar 04; 298(6673):561-4. PubMed ID: 2467711 [Abstract] [Full Text] [Related]
4. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. Corbin DO, Wood DA, Macintyre CC, Housley E. Eur Heart J; 1986 Feb 04; 7(2):165-70. PubMed ID: 3516704 [Abstract] [Full Text] [Related]
6. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis. Meyrick Thomas RH, Rademaker M, Grimes SM, MacKay A, Kovacs IB, Cook ED, Bowcock SM, Kirby JD. Br J Dermatol; 1987 Aug 04; 117(2):237-41. PubMed ID: 3307894 [Abstract] [Full Text] [Related]
7. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Smith CD, McKendry RJ. Lancet; 1982 Dec 11; 2(8311):1299-301. PubMed ID: 6128596 [Abstract] [Full Text] [Related]
9. Slow release nifedipine in the treatment of Raynaud's phenomenon. Costantini A, Martelli E, Bavera P, Agus GB. Int Angiol; 1987 Dec 11; 6(4):359-63. PubMed ID: 3330116 [Abstract] [Full Text] [Related]
10. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon. Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL. Am Heart J; 1986 Apr 11; 111(4):742-5. PubMed ID: 3513504 [Abstract] [Full Text] [Related]
11. Nifedipine in the treatment of Raynaud's syndrome. Aldoori M, Campbell WB, Dieppe PA. Cardiovasc Res; 1986 Jun 11; 20(6):466-70. PubMed ID: 3536108 [Abstract] [Full Text] [Related]
12. Nifedipine as a therapeutic modality for Raynaud's phenomenon. Winston EL, Pariser KM, Miller KB, Salem DN, Creager MA. Arthritis Rheum; 1983 Oct 11; 26(10):1177-80. PubMed ID: 6626276 [Abstract] [Full Text] [Related]
13. Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine. Morgan RH, Psaila JV, Davies WT, Carolan G, Woodcock JP. Eur J Vasc Surg; 1987 Dec 11; 1(6):403-8. PubMed ID: 3503035 [Abstract] [Full Text] [Related]
14. Treatment of Raynaud's phenomenon with calcium channel blockers. Smith CR, Rodeheffer RJ. Am J Med; 1985 Feb 22; 78(2B):39-42. PubMed ID: 3976694 [Abstract] [Full Text] [Related]
15. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects. Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H. J Rheumatol; 1987 Apr 22; 14(2):284-90. PubMed ID: 3598997 [Abstract] [Full Text] [Related]
16. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon. Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS. Angiology; 1989 Feb 22; 40(2):122-8. PubMed ID: 2644877 [Abstract] [Full Text] [Related]
17. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon. Creager MA, Pariser KM, Winston EM, Rasmussen HM, Miller KB, Coffman JD. Am Heart J; 1984 Aug 22; 108(2):370-3. PubMed ID: 6380254 [Abstract] [Full Text] [Related]